Skip to main content
. 2013 Apr 1;110(17):7044–7049. doi: 10.1073/pnas.1303510110

Fig. 1.

Fig. 1.

Candidate hits from PrP-FEHTA screen and counterscreen. (A) PrP expression levels as a percentage of the DMSO control measured by PrP-FEHTA. DMSO control is shown for each plate (plates shown as separate graphs). Brefeldine A (BFA) control reduced PrP to background in all plates. Z′ was 0.7 for all four plates. (B) Cell viability measured by CellTiter-Glo (counterscreen). Cutoffs (50% for PrP expression, ≤10% toxicity) are indicated by dotted lines. Surprisingly and interestingly, some drugs from this FDA-approved collection exhibited toxicity in vitro at 20 µM.